CDKN1A and neoplasm: However, PTL was a potent drug to induce the S-phase arrest in nonpromoted cells and block tumor-promoted cells at S to G2/M phases as well as to modulate the p65 binding and chromatin structure on p21 and cyclin D1 promoters regulating their gene expression.